-
-
Enroll in the Living With Type 2 Diabetes Program
Recently diagnosed? Let us guide you during your first year.
-
-
-
Volunteer Center
There are life-changing opportunities in your community to inspire healthy living, advocate for change, and help with events.
-
-
About Us
New to Type 2?
Enroll in the Living With Type 2 Diabetes program and let us guide you through your first year with type 2 diabetes.
Harold Rifkin Award for Distinguished International Service in the Cause of Diabetes
Rury Holman, FRCP
Rury Holman, from Oxford, United Kingdom, received the American Diabetes Association’s prestigious 2011 Harold Rifkin Award for Distinguished International Service in the Cause of Diabetes. The award was presented at the Association’s 71st Scientific Sessions in San Diego, California.
The Harold Rifkin Award honors individual outstanding service in the cause of diabetes that has been performed with an international perspective and with international impact.
Holman, the first professor of diabetic medicine to be appointed at the University of Oxford, United Kingdom, has a longstanding commitment to the conduct of major clinical trials in the field of diabetes. He advises groups worldwide on the design and management of clinical trials, ensuring that major unanswered questions are addressed and important hypotheses tested.
A senior investigator with the National Institute for Health Research, Holman is best known for his work with the United Kingdom Prospective Diabetes Study (UKPDS) and remains committed to large-scale clinical research, with a focus on type 2 diabetes prevention and treatment, and cardiovascular risk reduction. Holman is joint chair of the NAVIGATOR, TECOS, and EXSCEL trials, and chief investigator of the 4-T and ACE trials.
As director of the Diabetes Trials Unit at Oxford, Holman has mentored an international group of clinicians, statisticians and clinical researchers. In 2009, he launched a cardiovascular outcome trial in China, overseeing the training of endocrinologists and cardiologists in clinical trial methodology so they can design, coordinate, and report first-rate trials in China. He encourages innovation in the statistical methodology applied to analyzing trials.
